Back
NewAmsterdam Pharma Co NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
45
NAMS
NewAmsterdam Pharma Co NV
Last Price:
18.93
Seasonality Move:
88.46%
Sell
33
PRQR
ProQR Therapeutics NV
Last Price:
3.47
Seasonality Move:
18.95%
Sell
45
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV a Buy, Sell or Hold?
- The current NewAmsterdam Pharma Co NV [NAMS] share price is $19.13. The Score for NAMS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NAMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.31. The Score for PRQR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NAMS Stock Price Chart
What is NewAmsterdam Pharma Co NV's stock price today?
-
The NewAmsterdam Pharma Co NV share price today is $19.13
The current trend is moderately bullish and NAMS is experiencing slight buying pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
NAMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 64.09 | Buy |
| Chaikin Money Flow: | 95619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.51 - 19.11) | Buy |
| Bollinger Bands (100): | (16.27 - 19.37) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 60.63 | Buy |
| Chaikin Money Flow: | -307452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 3.35) | Buy |
| Bollinger Bands (100): | (1.46 - 2.54) | Buy |
NAMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.07 | Buy |
| 20-day SMA: | 18.35 | Buy |
| 50-day SMA: | 17.01 | Buy |
| 200-day SMA: | 19.35 | Sell |
| 8-day EMA: | 18.96 | Buy |
| 20-day EMA: | 18.34 | Buy |
| 50-day EMA: | 17.71 | Buy |
| 200-day EMA: | 17.44 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.74 | Sell |
| 20-day SMA: | 2.61 | Buy |
| 50-day SMA: | 2.19 | Buy |
| 200-day SMA: | 2.05 | Buy |
| 8-day EMA: | 3.34 | Sell |
| 20-day EMA: | 2.85 | Buy |
| 50-day EMA: | 2.37 | Buy |
| 200-day EMA: | 2.04 | Buy |
NewAmsterdam Pharma Co NV Earnings Growth & NAMS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.65 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
NewAmsterdam Pharma Co NV Technical Analysis
| Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||